CirculoGene Theranostics

About:

CirculoGene specializes in the fields of cfDNA, liquid biopsy, tumor monitoring, laboratory testing, and molecular diagnostics.

Website: http://www.circulogene.com

Twitter/X: _circulogene

Description:

CirculoGene is a biotechnology company that specializes in the fields of cfDNA, liquid biopsy, tumor monitoring, laboratory testing, and molecular diagnostics. its proprietary laboratory-developed test for cfDNA, cRNA, and MSI liquid biopsies, CIRCULOGENE has developed a next-generation sequencing (NGS) method to provide full genomic load analysis from one standard tube of blood in one week, enabling more accurate data to help clinicians and their patients choose targeted therapies, monitor efficacy and monitor for recurrence. The company was founded in 2015 and is headquartered in Birmingham, Alabama.

Total Funding Amount:

$24.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Birmingham, Alabama, United States

Founded Date:

2015-01-01

Contact Email:

info(AT)circulogene.com

Founders:

Chen- Hsiung Yeh, Michael Mullen, Scott Rezek

Number of Employees:

51-100

Last Funding Date:

2023-03-24

IPO Status:

Private

Industries:

© 2025 bioDAO.ai